Commonality of complex diseases

Dr. Alice Limonciel
biocrates life sciences ag
Innsbruck | Austria
Part of the Symposium:
Metabolomics India 2023 - Clinical applications
In spite of substantial research funding over the past three decades, the prevalence of complex chronic diseases continues to rise, while identifying early markers, effective treatments, and preventive strategies remains an ongoing challenge. This talk provides a new perspective on complex chronic diseases traditionally studied separately: Alzheimer’s, depression, multiple sclerosis, inflammatory bowel disease, type 1 diabetes, and cancers, by examining them through the prism of metabolomics. The models shown of priming for complex chronic diseases confirm the significance of the gut microbiome for many conditions, reveal new potential druggable targets, and provide a proof-of-principle for the broader use of metabolomics in the study of complex chronic diseases.
Dr. Limonciel @LinkedIn: / alice-limonciel
Download whitepaper "Complex chronic diseases have a common origin": biocrates.com/...
biocrates.com/